SO
FHTX icon

STRS Ohio’s Foghorn Therapeutics FHTX Stock Holding History

STRS Ohio’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Hold
8,600
– – ﹤0.01% 2042
2026
Q1 		$41.1K Hold
8,600
– – ﹤0.01% 1967
2025
Q4 		$46.4K Buy
8,600
+4,700
+121% +$21.3K ﹤0.01% 1994
2025
Q3 		$19.1K Buy
+3,900
New +$20.7K ﹤0.01% 2121
2021
Q1 		– Sell
-1,700
Closed -$34K – 2207
2020
Q4 		$34K Buy
+1,700
New +$32.6K ﹤0.01% 2032

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

STRS Ohio's FHTX Position: Q2 2026 in Review

STRS Ohio held its Foghorn Therapeutics (FHTX) position steady in Q2 2026 at 8,600 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

STRS Ohio first reported a position in FHTX in Q4 2020 and has held it in 5 quarters since. The position peaked at $46.4K in Q4 2025. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • STRS Ohio held 8,600 shares of Foghorn Therapeutics worth $42K as of Q2 2026.
  • STRS Ohio left its Foghorn Therapeutics share count unchanged in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2042 holding.
  • STRS Ohio first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 5 quarters since.
  • STRS Ohio's Foghorn Therapeutics position peaked at $46.4K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.